Remove 2018 Remove DEA Remove Programs Remove Safety
article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA. More CBD Coverage.

DEA 51
article thumbnail

Empire State Cannabis Update: CCB Makes Progress In Hemp Program & Chair Hints At Adult-Use Timeline

Cannabis Law Report

Cannabinoid Hemp Program Regulations (Finally) Finalized. While much attention is focused on New York’s adult-use cannabis market, the CCB and Office of Cannabis Management (OCM) are also responsible for overseeing both the Medical Marijuana and Cannabinoid Hemp Programs. CBD products).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Video – US Hemp Roundtable: House Agriculture Leaders Urge Congress To Regulate CBD In Upcoming Farm Bill

Cannabis Law Report

An Examination of the USDA Hemp Production Program. Hemp Roundtable Vice President and CEO of Kentucky-based Ecofibre, Eric Wang, testified alongside Kentucky Commissioner of Agriculture, Ryan Quarles, during a Congressional hearing regarding “ An Examination of the USDA’s Hemp Production Program.” Washington D.C.

article thumbnail

OLCC Inspectors Instrumental in Discovery of Illegal Marijuana Oil Processing Operation in Lane County

Cannabis Law Report

The illicit extraction operation was detected by OLCC inspectors at an out-of-compliance Oregon Medical Marijuana Program (OMMP) medical grow site. Inspectors from the OLCC OMMP Marijuana Tracking Program were making a proactive check on the Lane County location which had been registered as an OMMP (GSA) grow site.

Oil 45
article thumbnail

Cannabis Administration And Opportunity Act: What The Proposed Federal Cannabis Laws Would Mean For Hemp

Cannabis Law Report

It also includes comprehensive restorative justice provisions, including grants, loans, and other funding programs for disadvantaged and minority businesses, record expungement, petitions for resentencing, and other measures intended to repair the decades of harm caused by the War on Drugs. Regulatory Oversight of Hemp and Cannabis.

Hemp 105
article thumbnail

New Frontiers in the Law of Psychedelics

Cannabis Law Report

Beginning in 2018, the FDA has started to grant special designations to study the medicinal use of psilocybin via Breakthrough Therapy status. In May 2018, the federal Right to Try Act (the “Act”) was signed into law. Drug Enforcement Agency (“DEA”). Since May 2014, 41 states have enacted Right to Try laws. AIMS Institute, PLLC.

Law 105
article thumbnail

Buyer Beware: Unlicensed CBD Products Could Contain a “Powerful Street Drug”

WeedAdvisor

In May of 2018, a man named Jay Jenkins entered a coma after inhaling just two puffs of a “CBD” vape liquid laced with the synthetic drug. For instance, Jenkins’s case mentioned above happened in 2018, yet did not receive attention until September 2019. Hemp Authority, which has a certification program for various CBD health products.

CBD 45